Conformational flexibility and binding energy profile of c-Abl tyrosine kinase complexed with Imatinib: an insight from MD study

被引:1
|
作者
Dubey, Kshatresh D. [1 ]
Ojha, Rajendra P. [1 ]
机构
[1] DDU Gorakhpur Univ, Dept Phys, Biophys Unit, Gorakhpur 273009, Uttar Pradesh, India
关键词
MM-PBSA method; salt bridges; protein hydration; SOLVATED INTERACTION ENERGY; CHRONIC MYELOID-LEUKEMIA; CANCER DRUG IMATINIB; MOLECULAR-DYNAMICS; PROTEIN INTERACTIONS; STRUCTURAL BASIS; FORCE-FIELD; BCR-ABL; INHIBITION; DASATINIB;
D O I
10.1080/08927022.2011.586346
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Structural biology of kinase and in particular of tyrosine kinase has given detailed insights into the intrinsic flexibility of the catalytic domain and has provided a rational basis for obtaining selective inhibitors. In this paper, we have studied the conformational flexibility of c-Abl tyrosine kinase complexed with Imatinib (STI), in the presence of TIP3P water in physiological conditions at neutral pH. The conformational studies suggest that the flexibility of activation loop is responsible to facilitate the nucleotide binding and release. Owing to the conformational adaptability, adenosine triphosphate (ATP) binds at a particular site in the loop region of the tyrosine kinase. The molecular mechanics Poisson-Boltzmann surface area methods are analysed, as is a free-energy pathways method, which shows the stable binding with free energy - 6.04 kcal/mol for STI. The binding energy calculated by the Sietraj method is approximately the same as the experimental binding energy of STI with c-Abl kinase. It is suggested that the conserved glutamic acid and lysine residues are necessary for the stability and optimum activity of inhibitor. This study may be helpful in rational drug designing of new kinase inhibitors.
引用
收藏
页码:1151 / 1163
页数:13
相关论文
共 32 条
  • [1] Tyrosine kinase inhibition: Ligand binding and conformational change in c-Kit and c-Abl
    Healy, Eamonn F.
    King, Peter J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [2] Tyrosine kinase inhibition: Ligand binding and conformational change in c-Kit and c-Abl
    Healy, Eamonn F.
    Johnson, Skylar
    Hauser, Charles R.
    King, Peter J.
    FEBS LETTERS, 2009, 583 (17) : 2899 - 2906
  • [3] Conformational flexibility, binding energy, role of salt bridge and alanine-mutagenesis for c-Abl kinase complex
    Dubey, Kshatresh Dutta
    Ojha, Rajendra Prasad
    JOURNAL OF MOLECULAR MODELING, 2012, 18 (05) : 1679 - 1689
  • [4] Conformational flexibility, binding energy, role of salt bridge and alanine-mutagenesis for c-Abl kinase complex
    Kshatresh Dutta Dubey
    Rajendra Prasad Ojha
    Journal of Molecular Modeling, 2012, 18 : 1679 - 1689
  • [5] c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution
    Badger, John
    Grover, Prerna
    Shi, Haibin
    Panjarian, Shoghag B.
    Engen, John R.
    Smithgall, Thomas E.
    Makowski, Lee
    BIOCHEMISTRY, 2016, 55 (23) : 3251 - 3260
  • [6] CELL-CYCLE REGULATED BINDING OF C-ABL TYROSINE KINASE TO DNA
    KIPREOS, ET
    WANG, JYJ
    SCIENCE, 1992, 256 (5055) : 382 - 385
  • [7] c-Abl tyrosine kinase and inhibition by the cancer drug imatinib (Gleevec/STI-571)
    Nagar, Bhushan
    JOURNAL OF NUTRITION, 2007, 137 (06): : 1518S - 1523S
  • [8] The Tyrosine Kinase Arg, But Not c-Abl is the Molecular Target in the Endothelial Barrier Protective Effects of Imatinib
    Aman, Jurjan
    van Bezu, Jan
    Noordegraaf, Anton Vonk
    Groeneveld, A. B. J.
    van Hinsbergh, Victor W.
    Amerongen, Geerten P. van Nieuw
    CIRCULATION, 2011, 124 (21)
  • [9] ACTIVATION OF TYROSINE KINASE AND MICROFILAMENT-BINDING FUNCTIONS OF C-ABL BY BCR SEQUENCES IN BCR/ABL FUSION PROTEINS
    MCWHIRTER, JR
    WANG, JYJ
    MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (03) : 1553 - 1565
  • [10] Interaction between UV-damaged DNA binding activity proteins and the c-Abl tyrosine kinase
    Cong, F
    Tang, J
    Hwang, BJ
    Vuong, BQ
    Chu, G
    Goff, SP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) : 34870 - 34878